Filtros de búsqueda

Lista de obras de Corinne Haioun

A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patient

artículo científico publicado en 2012

A dose-escalation study of SAR3419, an anti-CD19 antibody maytansinoid conjugate, administered by intravenous infusion once weekly in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.

artículo científico publicado en 2013

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.

artículo científico publicado en 2018

A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: the EXPECT trial

artículo científico publicado en 2013

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymp

artículo científico publicado en 2016

All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

artículo científico publicado en 2004

An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.

artículo científico publicado en 2013

An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma

artículo científico publicado en 2011

Analysis of the intraclonal diversity of HLA-A0201-restricted T lymphocyte epitopes in follicular lymphoma idiotype

scientific article published on 01 February 2006

Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational study

artículo científico publicado en 2011

Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups

artículo científico publicado en 2013

Authors' Reply

scientific article published on 01 March 2018

Autologous hematopoietic stem cell transplantation in intermediate and high grade non-Hodgkin's lymphoma: a review.

artículo científico publicado en 1993

Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2.

artículo científico publicado en 2007

BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial.

artículo científico publicado en 2017

Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies.

artículo científico publicado en 2016

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

artículo científico publicado en 1997

Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases.

artículo científico publicado en 2016

Bone marrow histologic and immunohistochemical findings in peripheral T-cell lymphoma: A study of 38 cases

scientific article published on 01 April 1991

Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution

scientific article published on 01 July 2001

CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas

artículo científico publicado en 1996

CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte.

artículo científico publicado en 2012

Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies.

artículo científico publicado en 2018

Characterization of CXCL13+ neoplastic t cells in cutaneous lesions of angioimmunoblastic T-cell lymphoma (AITL)

scientific article published on 01 July 2007

Clinical impact of contrast-enhanced computed tomography combined with low-dose (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management

artículo científico publicado en 2014

Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphoma

scientific article published on 30 September 2011

Clinical research activity of the French cancer cooperative network: Overview and perspectives

artículo científico publicado en 2017

Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials

artículo científico publicado en 2008

Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group

artículo científico publicado en 2017

Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma

artículo científico publicado en 2020

Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte

artículo científico publicado en 1997

Comparison of autografting using mobilized peripheral blood stem cells with and without granulocyte colony-stimulating factor in malignant lymphomas

artículo científico publicado en 1994

Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.

artículo científico publicado en 1994

Comparison of genetic probe with immunophenotype analysis in lymphoproliferative disorders: a study of 87 cases

scientific article published on 01 December 1988

Complete remission of gastric Burkitt's lymphoma after eradication of Helicobacter pylori

artículo científico publicado en 2009

Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment

artículo científico publicado en 2017

Cutaneous lymphomas other than mycosis fungoides: follow-up study of 52 patients.

artículo científico publicado en 1991

DIFFUSE LARGE B-CELL LYMPHOMA-ASSOCIATED-RETINOPATHY CHARACTERIZED BY MINIMAL MORPHOLOGIC CHANGES AND SEVERE FUNCTIONAL IMPAIRMENT.

artículo científico publicado en 2016

Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (±R) CHOP

scientific article published on 12 September 2012

Darier's sign in cutaneous large T-cell lymphoma

scientific article published on 01 March 1996

Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier: A CALYM Study.

artículo científico publicado en 2017

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.

artículo científico publicado en 2018

Diagnostic yield of bronchoalveolar lavage in pneumonitis occurring after allogeneic bone marrow transplantation

artículo científico publicado en 1985

Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study.

artículo científico publicado en 2012

Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study.

artículo científico publicado en 2010

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.

artículo científico publicado en 2013

Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial.

artículo científico publicado en 1998

Duodenal mucosa-associated lymphoid tissue lymphoma: treatment with oral cyclophosphamide

artículo científico publicado en 2000

EZH2 alterations in follicular lymphoma: biological and clinical correlations.

artículo científico publicado en 2017

Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.

artículo científico publicado en 2007

Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA

artículo científico publicado en 2009

Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: a randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

artículo científico publicado en 2012

Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study

scientific article published on 01 February 2000

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

artículo científico publicado en 2018

Endoscopic ultrasonography for the initial staging and follow-up in patients with low-grade gastric lymphoma of mucosa-associated lymphoid tissue treated medically

artículo científico publicado en 1997

Enteropathy-Associated T-Cell Lymphoma Complicating an Autoimmune Enteropathy

artículo científico publicado en 2012

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma.

artículo científico publicado en 2016

Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy.

artículo científico publicado en 2014

Expression of CXCL13 by Neoplastic Cells in Angioimmunoblastic T-Cell Lymphoma (AITL)

artículo científico publicado en 2006

Expression of TFH Markers and Detection of RHOA p.G17V and IDH2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas

artículo científico publicado en 2017

Expression of the alpha beta and gamma delta T-cell receptors in peripheral T-cell lymphomas

scientific article published on 01 January 1990

Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas

artículo científico publicado el 1 de septiembre de 1990

Extensive telangiectases of the scalp: atypical presentation of primary cutaneous follicle centre lymphoma

artículo científico publicado en 2012

FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts

artículo científico

FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study

artículo científico publicado en 2017

Failure of combination chemotherapy of advanced follicular (low-grade) non-Hodgkin's lymphoma

artículo científico publicado en 1987

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.

artículo científico publicado en 2017

Flow cytometric immunophenotyping of cerebrospinal fluid

artículo científico publicado en 2008

Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'Adulte

scientific article published on 01 October 1999

Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics

artículo científico publicado en 2012

Folliculotropic T-cell infiltrates associated with B-cell chronic lymphocytic leukaemia or MALT lymphoma may reveal either true mycosis fungoides or pseudolymphomatous reaction: seven cases and review of the literature

artículo científico publicado en 2014

Gastric lymphoma: role of Helicobacter pylori

artículo científico publicado en 1997

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

scientific article published on 19 February 2019

Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes

artículo científico publicado en 2019

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

artículo científico publicado en 2016

Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

artículo científico publicado en 2014

Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type

artículo científico publicado en 2001

Hematopoietic growth factors in treatment of necrotizing cellulitis patients with drug-induced neutropenia

scientific article published on 01 January 1993

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

article

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma

artículo científico publicado en 2015

High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma.

artículo científico publicado en 1998

High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol

scientific article published on 01 December 2000

IL-12 secreting dendritic cells are required for optimum activation of human secondary lymphoid tissue T cells

artículo científico publicado en 2002

Immunoblastic lymphoma involving the bone marrow in a patient with alpha chain disease. Clinical and immunoelectron microscopic study

artículo científico publicado en 1985

Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma.

artículo científico publicado en 2013

Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels

artículo científico publicado en 2014

Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network

artículo científico publicado en 2017

Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and G

artículo científico

Impact of doxorubicin dose capping on the outcome of DLBCL patients with elevated body surface area.

artículo científico publicado en 2017

Impact of high-dose chemotherapy on peripheral T-cell lymphomas

scientific article published on 01 March 2002

Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study.

artículo científico publicado en 2008

Impact of rituximab on stem cell mobilization following ACVBP regimen in poor-risk patients with diffuse large B-cell lymphoma: results from a large cohort of patients.

artículo científico publicado en 2012

Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice

artículo científico publicado en 2012

Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: importance of the reference background.

artículo científico publicado en 2010

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.

artículo científico publicado en 2004

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lympho

scientific article published on 01 June 2000

Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin

artículo científico publicado en 2017

Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma

scientific article published on 01 October 1995

Interim 18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation--where do we stand?

artículo científico publicado en 2009

Interim [18F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximab.

artículo científico publicado en 2011

Intravascular large cell lymphoma revealed by diffuse telangiectasia and cauda equina syndrome

artículo científico publicado en 2002

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.

artículo científico publicado en 2017

Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study

artículo científico publicado en 2018

Liver transplantation for fulminant hepatitis following chemotherapy for malignant lymphoma

artículo científico publicado en 1990

Long-term course of precancerous lesions arising in patients with gastric MALT lymphoma.

artículo científico publicado en 2017

Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study

article

Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

artículo científico publicado en 2009

Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study

artículo científico publicado en 2007

Long-term follow-up of lenalidomide in relapsed/refractory mantle cell lymphoma: subset analysis of the NHL-003 study

artículo científico publicado en 2013

Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials

artículo científico

Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study

artículo científico publicado en 2017

Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies

artículo científico publicado en 2015

Low grade B cell mucosa associated lymphoid tissue lymphoma of the stomach: clinical and endoscopic features, treatment, and outcome

artículo científico publicado el 1 de diciembre de 1992

Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma

artículo científico publicado en 2017

Lymphoma: imaging in the evaluation of residual masses.

artículo científico publicado en 2002

MR appearance of multiple myeloma of the spine before and after treatment

artículo científico publicado en 1993

MRI and PET of bone marrow in lymphoproliferative diseases.

artículo científico publicado en 2003

Management of relapsed or refractory follicular lymphoma patients in daily practice - a French non-interventional study

artículo científico publicado en 2018

Mediastinal diffuse large-cell lymphoma with sclerosis: a condition with a poor prognosis

artículo científico publicado en 1989

Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?

article

Minimal change nephrotic syndrome associated with non-Hodgkin lymphoid disorders: a retrospective study of 18 cases

artículo científico publicado en 2014

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

artículo científico publicado en 2003

Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing

scientific article published on 05 July 2018

New insights into breast implant-associated anaplastic large cell lymphoma

artículo científico publicado en 2018

Obinutuzumab (GA101) monotherapy in relapsed/refractory diffuse large b-cell lymphoma or mantle-cell lymphoma: results from the phase II GAUGUIN study.

artículo científico publicado en 2013

Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study

artículo científico publicado en 2018

Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma

scientific article published on 20 November 2018

PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphoma.

artículo científico publicado en 2014

Patients with plasma cell disorders examined at whole-body dynamic contrast-enhanced MR imaging: initial experience.

artículo científico publicado en 2009

Percutaneous Fine Needle Aspiration Cytology and Biopsy in the Diagnosis and Classification of Lymphoma: Clinical Evaluation

artículo científico publicado en 1991

Peripheral T-cell lymphoma presenting as predominant liver disease: a report of three cases

artículo científico publicado en 1986

Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma.

artículo científico publicado en 2007

Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2015

Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma

artículo científico publicado en 2012

Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.

artículo científico publicado en 2000

Phase II study of oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.

artículo científico publicado en 2018

Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe d'Etude des Lymphomes de l'Adulte trial.

artículo científico publicado en 2009

Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte

artículo científico publicado en 1996

Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)

artículo científico publicado en 2012

Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.

artículo científico publicado en 1997

Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study

artículo científico publicado en 2011

Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL study

artículo científico publicado en 2012

Pregnancies after high-dose chemotherapy and autologous stem cell transplantation in aggressive lymphomas

scientific article published on 01 July 2002

Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma.

artículo científico publicado en 2014

Primary cutaneous lymphoma, with the exception of mycosis fungoides

artículo científico publicado en 1992

Prognostic model for high tumor burden follicular lymphoma integrating baseline and end induction PET: a LYSA/FIL study.

artículo científico publicado en 2018

Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA).

artículo científico publicado en 1998

Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

artículo científico publicado en 1996

Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: Application to LNH-87 protocol

artículo científico publicado en 1993

Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies

artículo científico publicado en 2014

Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy.

artículo científico publicado en 2009

Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy

artículo científico publicado en 2005

Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL)

artículo científico publicado en 2018

Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials

artículo científico publicado en 2018

Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplant.

artículo científico publicado en 2011

Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (G

artículo científico publicado en 2000

Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte

scientific article published on 01 November 1993

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma

artículo científico publicado en 2016

Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma

artículo científico publicado en 2014

Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assay

artículo científico publicado en 2017

Reply to H.J.A. Adams et al and E. Laffon et al

scientific article published on 28 December 2016

Report of the 6th International Workshop on PET in lymphoma

artículo científico publicado en 2017

Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3-5 October 2012.

artículo científico publicado en 2013

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

artículo científico publicado en 2009

Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8–9 April 2010

artículo científico publicado el 15 de noviembre de 2010

Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26-27 September 2011 and Menton 2011 consensus.

artículo científico publicado en 2012

Respective prognostic values of germinal center phenotype and early (18)fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma.

artículo científico publicado en 2007

Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation

artículo científico publicado en 2001

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study

artículo científico publicado en 1998

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.

artículo científico publicado en 2017

Rituximab and chlorambucil versus rituximab alone in gastric mucosa-associated lymphoid tissue lymphoma according to t(11;18) status: a monocentric non-randomized observational study.

artículo científico publicado en 2012

Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report

artículo científico publicado en 2017

Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up

artículo científico publicado en 2012

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

artículo científico publicado en 2010

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

artículo científico publicado en 2018

Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial

artículo científico publicado en 2013

Rituximab, alkylating agents or combination therapy for gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomised observational study

artículo científico publicado en 2014

Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy.

artículo científico publicado en 2007

Role of up-front autologous stem cell transplantation in peripheral T-cell lymphoma for patients in response after induction: An analysis of patients from LYSA centers

artículo científico publicado en 2017

SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma.

artículo científico publicado en 2011

Sarcoidosis occurring after lymphoma: report of 14 patients and review of the literature.

artículo científico publicado en 2014

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients

artículo científico publicado en 2003

Second primary malignancies in patients treated for gastric mucosa-associated lymphoid tissue lymphoma

article by Aurelien Amiot et al published 31 January 2017 in Leukemia & Lymphoma

Secondary pancreatic involvement by diffuse large B-cell lymphoma presenting as acute pancreatitis: treatment and outcome.

artículo científico publicado en 2002

Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma

artículo científico publicado en 2015

Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma

scientific article published on 14 February 2020

Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis

artículo científico publicado en 2003

Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lympho

artículo científico publicado en 2006

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

artículo científico publicado en 2008

Successful long-term outcome of the first combined heart and kidney transplant in a patient with systemic Al amyloidosis.

artículo científico publicado en 2008

Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma

artículo científico publicado en 2003

Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.

artículo científico publicado en 2011

Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA

artículo científico publicado en 2012

The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development

artículo científico publicado en 2016

The MAL gene is expressed in primary mediastinal large B-cell lymphoma

scientific article published on 01 November 1999

The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association.

artículo científico publicado en 2015

The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.

artículo científico publicado en 2008

The need for improved neutropenia risk assessment in DLBCL patients receiving R-CHOP-21: findings from clinical practice.

artículo científico publicado en 2012

The usefulness of phenotypic and genotypic studies in malignant lymphoma and related disorders

scientific article published on 01 January 1989

Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma

artículo científico publicado en 2018

Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma

scholarly article by François Lemonnier et al published 2 October 2018 in Blood

Use of Model-Based Iterative Reconstruction (MBIR) in reduced-dose CT for routine follow-up of patients with malignant lymphoma: dose savings, image quality and phantom study.

artículo científico publicado en 2015

Value of [18F]fluorodeoxyglucose-positron emission tomography in managing patients with aggressive non-Hodgkin's lymphoma.

artículo científico publicado en 2006

Whole body MRI and PET/CT in haematological malignancies.

artículo científico publicado en 2007

Whole-Body Diffusion-weighted Imaging in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma

artículo científico

Whole-Body Diffusion-weighted MR Imaging of Iron Deposits in Hodgkin, Follicular, and Diffuse Large B-Cell Lymphoma

artículo científico publicado en 2017

Whole-body DWI in patients with lymphoma: imaging findings, pitfalls, and limitations

artículo científico publicado en 2014

Whole-body diffusion magnetic resonance imaging in the assessment of lymphoma.

artículo científico publicado en 2012

Whole-body diffusion-weighted imaging in lymphoma.

artículo científico publicado en 2010

Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study

scientific article published on 01 May 2011

Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma

artículo científico publicado en 2010

Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/

artículo científico publicado en 2014

ZOHé: A Prospective Study of the Use of Biosimilar Filgrastim Zarzio in Clinical Practice in Patients Treated With Chemotherapy for Lymphoid Malignancies.

artículo científico publicado en 2017

[18F]-FDG positron imaging in clinical management of lymphoma patients.

artículo científico publicado en 2001

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

artículo científico publicado en 2005

[Aggressive lymphomas]

artículo científico publicado en 2002

[Bone marrow necrosis disclosing multiple myeloma of bone]

scientific article published on 01 October 1985

[CD30 (Ki-1+) anaplastic large cell lymphomas]

scientific article published on 01 January 1989

[Leg ulcer associated with type I cryoglobulinaemia due to incipient B-cell lymphoma]

artículo científico publicado en 2013

[Non epidermotropic T lymphoma preceded for several years by hypereosinophilic syndrome]

artículo científico publicado en 1990

[Non-Hodgkin lymphoma in the elderly]

artículo científico publicado en 2008

[Non-epidermotropic cutaneous lymphomas]

artículo científico publicado en 1987

[Systemic capillary leak syndrome disclosing mixed diffuse T lymphoma]

artículo científico publicado en 1991

[Treatment of gastric lymphomas. The role of surgery must be revisited]

artículo científico publicado en 1992

[Treatment of large-cell gastric lymphoma: comparison of the efficacy of radiochemotherapy alone or combined with first gastrectomy]

artículo científico publicado en 1996

[Whole body functional MR imaging: hemato-oncologic applications]

scientific article published on 01 March 2010

p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas.

artículo científico publicado en 2002